11/17/2017 Liz Ahlberg Touchstone, Illinois News Bureau
Written by Liz Ahlberg Touchstone, Illinois News Bureau
Specially tailored, ultrafast pulses of light can trigger neurons to fire and could one day help patients with light-sensitive circadian or mood problems, according to a new study in mice led by Abel Bliss Professor of Engineering Stephen Allen Boppart. Boppart is a professor of electrical and computer engineering and of bioengineering, a medical doctor, affiliated with the Beckman Institute, and the leader of the study published in the journal Nature Physics.
“The saying, ‘The eye is the window to the soul’ has some merit, because our bodies respond to light. Photoreceptors in our retinas connect to different parts in the brain that control mood, metabolic rhythms and circadian rhythms,” said Dr. Boppart.
The researchers used light to excite a light-sensitive channel in the membrane of neurons. When the channels were excited, they allowed ions through, which caused the neurons to fire.
While most biological systems in nature are accustomed to the continuous light from the sun, Boppart’s team used a flurry of very short light pulses – less than 100 femtoseconds. This delivers a lot of energy in a short period of time, exciting the molecules to different energy states. Along with controlling the length of the light pulses, Boppart’s team controls the order of wavelengths in each light pulse.
Boppart says coherent control could give optogenetics studies more flexibility, since changing properties of the light used can give researchers more avenues than having to give the mouse new genes every time they want a different neuron behavior.
Outside of optogenetics, the researchers are working to test their coherent control technique with naturally light-responsive cells and processes – retinal cells and photosynthesis, for example.
“What we’re doing for the very first time is using light and coherent control to regulate biological function. This is fundamentally more universal than optogenetics – that’s just the first example we used,” Boppart said. “Ultimately, this could be a gene-free, drug-free way of regulating cell and tissue function. We think there could be ‘opto-ceuticals,’ methods of treating patients with light.”
Visit the Illinois News Bureau for the original article. This news was also covered by R & D Magazine and Photonics.